Aim. To study the relationship between body mass index (BMI) and blood pressure (BP) on visual acuity among apparently healthy residents of Ekpoma, Esan West Local Government Area of Edo State, Nigeria. Methodology. This is a cross-sectional descriptive study among 225 subjects (ages of 18–35 years) from whom BP, body weight, and height were collected. Visual acuity was measured using the Snellen chart following standard procedures of number of letters seen at 6-metre distance. The data were then analyzed using SPSS version 17. Results. The sampled population consists of 112 male and 113 female (mean age years). Majority (180) of the respondents had normal visual acuity. However, compared with the respondents with normal BMI ( ; ), visual acuity of underweight ( ; ) and obese ( ; ) were more deviated. Similarly, compared with respondent with normal BP (120–125/80–85？mmHg; ; ), hypotensive ( ; ), and hypertensive ( ; ) respondents had deviated visual acuity. Conclusion. Abnormal body weight (underweight and obese) and BP (hypotension and hypertension) have potential negative impacts on visual acuity. Based on the observed relationship between weights, BP, and visual acuity, eye examinations can be included as regular screening exercise for abnormal BMI and BP conditions. 1. Background Obesity is a major public health problem with prevalence increasing at overwhelming rates [1–4]. It is implicated as a risk factor for several systemic diseases such as coronary heart disease [5], type 2 diabetes mellitus [6], hypertension, stroke, dyslipidemia, osteoarthritis, and sleep apnea [3, 7, 8]. Similarly, the global prevalence of hypertension is on the increase. In fact, a recent community based study of rural and semiurban population puts the prevalence of hypertension in Nigeria at 32.8% [9]. It is associated with serious end-organ damage such as heart disease, stroke, renal disease, and blindness [10–12], which can be prevented by adequate blood pressure control [13, 14]. Obesity has been reported to affect visual acuity negatively [15] but the ocular conditions underlying this association and the potential implications are unclear. Similarly, hypertension has been reported as a cause of blurred and altered vision [16–18]. In fact, in preeclampsia, a hypertensive emergency, vision loss is one serious complication according to O’Brien et al. [19] and Gibson [20]. According to several studies, visual impairment adds to the burden of several microvascular and macrovascular complications in people with diabetes and compromises quality of life [21–25]. Worrisome is
References
[1]
M. J. Friedrich, “Epidemic of obesity expands its spread to developing countries,” Journal of the American Medical Association, vol. 287, no. 11, pp. 1382–1386, 2002.
[2]
N. Friedman and E. L. Fanning, “Overweight and obesity: an overview of prevalence, clinical impact, and economic impact,” Disease Management, vol. 7, supplement 1, pp. S1–S6, 2004.
[3]
D. W. Haslam and W. P. T. James, “Obesity,” The Lancet, vol. 366, no. 9492, pp. 1197–1209, 2005.
[4]
J. O. Hill, V. Catenacci, and H. R. Wyatt, “Obesity: overview of an epidemic,” Psychiatric Clinics of North America, vol. 28, no. 1, pp. 1–23, 2005.
[5]
R. H. Eckel, R. M. Krauss, and AHA Nutrition Committee, “American Heart Association call to action: obesity as a major risk factor for coronary heart disease,” Circulation, vol. 97, no. 21, pp. 2099–2100, 1998.
[6]
S. M. Grundy, “Metabolic complications of obesity,” Endocrine, vol. 13, no. 2, pp. 155–165, 2000.
[7]
V. J. Lawrence and P. G. Kopelman, “Medical consequences of obesity,” Clinics in Dermatology, vol. 22, no. 4, pp. 296–302, 2004.
[8]
F. X. Pi-Sunyer, “Medical hazards of obesity,” Annals of Internal Medicine, vol. 119, no. 7, pp. 655–660, 1993.
[9]
I. I. Ulasi, C. K. Ijoma, and O. D. Onodugo, “A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria,” BMC Health Services Research, vol. 10, article 71, 2010.
[10]
M. D. Cressman and R. W. Gifford Jr., “Hypertension and stroke,” Journal of the American College of Cardiology, vol. 1, no. 2, pp. 521–527, 1983.
[11]
W. S. Post, M. N. Hill, C. R. Dennison, J. L. Weiss, G. Gerstenblith, and R. S. Blumenthal, “High prevalence of target organ damage in young, African American Inner-City men with hypertension,” Journal of Clinical Hypertension, vol. 5, no. 1, pp. 24–30, 2003.
[12]
S. Khakurel, R. K. Agrawal, and R. Hada, “Pattern of end stage renal disease in a tertiary care center,” Journal of the Nepal Medical Association, vol. 48, no. 174, pp. 126–130, 2009.
[13]
C. Cuspidi, L. Lonati, L. Sampieri et al., “Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control,” Journal of Hypertension, vol. 18, no. 6, pp. 803–809, 2000.
[14]
B. Neal, S. MacMahon, N. Chapman et al., “Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials,” The Lancet, vol. 356, no. 9246, pp. 1955–1964, 2000.
[15]
B. Bergman, H. Nilsson-Ehle, and J. Sj？strand, “Ocular changes, risk markers for eye disorders and effects of cataract surgery in elderly people: a study of an urban Swedish population followed from 70 to 97 years of age,” Acta Ophthalmologica Scandinavica, vol. 82, no. 2, pp. 166–174, 2004.
[16]
E. Rodriguez-Cruz and L. M. Ettinger, Hypertension, eMedicine Pediatrics: Cardiac Disease and Critical Care Medicin, Medscape, 2010.
[17]
J. M. Dionne, C. L. Abitbol, and J. T. Flynn, “Hypertension in infancy: diagnosis, management and outcome,” Pediatric Nephrology, vol. 27, no. 1, pp. 17–32, 2012.
[18]
N. D. Fisher and G. H. Williams, “Hypertensive vascular disease,” in Harrison's Principles of Internal Medicine, D. L. Kasper, E. Braunwald, A. S. Fauci, et al., Eds., pp. 1463–1481, McGraw-Hill, New York, NY, USA, 16th edition, 2005.
[19]
E. O'Brien, D. G. Beevers, and G. Y. H. Lip, ABC of Hypertension, BMJ Books, London, UK, 2007.
[20]
P. Gibson, “Hypertension and pregnancy,” eMedicine Obstetrics and Gynecology, Medscape, June 2009.
[21]
F. E. Hirai, J. M. Tielsch, B. E. K. Klein, and R. Klein, “Ten-year change in vision-related quality of life in type 1 diabetes: wisconsin epidemiologic study of diabetic retinopathy,” Ophthalmology, vol. 118, no. 2, pp. 353–358, 2011.
[22]
G. C. Jones, J. E. Crews, and M. L. Danielson, “Health risk profile for older adults with blindness: an application of the international classification of functioning, disability, and health framework,” Ophthalmic Epidemiology, vol. 17, no. 6, pp. 400–410, 2010.
[23]
J. Collerton, K. Davies, C. Jagger et al., “Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study,” British Medical Journal, vol. 339, Article ID b4904, 2009.
[24]
J. R. Evans, A. E. Fletcher, R. P. L. Wormald et al., “Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community,” British Journal of Ophthalmology, vol. 86, no. 7, pp. 795–800, 2002.
[25]
A. J. Sinclair, A. J. Bayer, A. J. Girling, and K. W. Woodhouse, “Older adults, diabetes mellitus and visual acuity: a community-based case-control study,” Age and Ageing, vol. 29, no. 4, pp. 335–339, 2000.
[26]
A. O. Obabori, R. Ebosele, and S. K. Mokidi, “Decay problems in cities: renewal options,” JABS, vol. 4, no. 1-2, pp. 144–153, 2006.
[27]
WHO, “Obesity preventive and managing the global epidemiology,” Report of a WHO Consultation on Obesity, Geneva, Switzerland, 1998.
[28]
M. C. Smith and F. A. Maure, Community Health Nursing Theory Practices, Elsevier Saunders, Philadelphia, Pa, USA, 1995.
[29]
V. Darling and M. Thorpe, Ophthalmic Nursing, Fakenhan Press, London, UK, 1975.
[30]
P. l. Garland, Ophthalmic Nursing, Faber and Faber, London, UK, 1995.
[31]
World Health Assembly (WHA), “The resolution of world health assembly on the elimination of avoidable blindness,” Community Eye Health, vol. 16, pp. 17–18, 2003.
[32]
G. N. Dennis and D. Paul, “School vision screening programme in enugu, Nigeria: assessment of referral criteria for error of refraction,” Nigerian Journal of Ophthalmology, pp. 34–40, 1997.
[33]
P. F. Jacques, S. M. Moeller, S. E. Hankinson et al., “Weight status, abdominal adiposity, diabetes, and early age-related lens opacities,” American Journal of Clinical Nutrition, vol. 78, no. 3, pp. 400–405, 2003.
[34]
B. E. K. Klein, R. Klein, K. E. Lee, and S. C. Jensen, “Measures of obesity and age-related eye diseases,” Ophthalmic Epidemiology, vol. 8, no. 4, pp. 251–262, 2001.
[35]
T. M. Kuang, S. Y. Tsai, W. M. Hsu, C. Y. Cheng, J. H. Liu, and P. Chou, “Body mass index and age-related cataract: the Shihpai eye study,” Archives of Ophthalmology, vol. 123, no. 8, pp. 1109–1114, 2005.
[36]
D. A. Schaumberg, W. G. Christen, S. E. Hankinson, and R. J. Glynn, “Body mass index and the incidence of visually significant age-related maculopathy in men,” Archives of Ophthalmology, vol. 119, no. 9, pp. 1259–1265, 2001.
[37]
J. M. Seddon, J. Cote, N. Davis, and B. Rosner, “Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio,” Archives of Ophthalmology, vol. 121, no. 6, pp. 785–792, 2003.
[38]
H. A. van Leiden, J. M. Dekker, A. C. Moll et al., “Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study,” Archives of Ophthalmology, vol. 121, no. 2, pp. 245–251, 2003.
[39]
E. R. Schoenfeld, M. C. Leske, and S.-Y. Wu, “Recent epidemiologic studies on nutrition and cataract in India, Italy and the United States,” Journal of the American College of Nutrition, vol. 12, no. 5, pp. 521–526, 1993.
[40]
E. A. Zang and E. L. Wynder, “The association between body mass index and the relative frequencies of diseases in a sample of hospitalized patients,” Nutrition and Cancer, vol. 21, no. 3, pp. 247–261, 1994.
[41]
M. C. Leske, A. M. S. Connell, S. Y. Wu, L. G. Hyman, and A. P. Schachat, “Risk factors for open-angle glaucoma: the Barbados eye study,” Archives of Ophthalmology, vol. 113, no. 7, pp. 918–924, 1995.
[42]
P. Gasser, D. Stümpfig, A. Sch？tzau, U. Ackermann-Liebrich, and J. Flammer, “Body mass index in glaucoma,” Journal of Glaucoma, vol. 8, no. 1, pp. 8–11, 1999.
[43]
H. Momeni-Moghaddam, J. Kundart, M. Ehsani, and A. Abdeh-Kykha, “Body mass index and binocular vision skills,” Saudi Journal of Ophthalmology, vol. 26, no. 3, pp. 331–334, 2012.
[44]
M. O. Ozor, I. O. Ernest-Nwoke, and M. O. Oyakhire, “Association between health status and visual functioning: a community based study,” International Journal of Community Research, vol. 3, no. 1, pp. 19–24, 2014.
[45]
A. J. Lee, J. J. Wang, A. Kifley, and P. Mitchell, “Open-angle glaucoma and cardiovascular mortality: the blue mountains eye study,” Ophthalmology, vol. 113, no. 7, pp. 1069–1076, 2006.
[46]
S. Y. Wu, B. Nemesure, A. Hennis, A. P. Schachat, L. Hyman, and M. C. Leske, “Open-angle glaucoma and mortality: the Barbados eye studies,” Archives of Ophthalmology, vol. 126, no. 3, pp. 365–370, 2008.
[47]
B. C. Chauhan, F. S. Mikelberg, A. G. Balaszi, R. P. LeBlanc, M. R. Lesk, and G. E. Trope, “Canadian glaucoma study: 2. Risk factors for the progression of open-angle glaucoma,” Archives of Ophthalmology, vol. 126, no. 8, pp. 1030–1036, 2008.
[48]
J. Flammer, K. Konieczka, R. M. Bruno, A. Virdis, A. J. Flammer, and S. Taddei, “The eye and the heart,” European Heart Journal, vol. 34, no. 17, pp. 1270–1278, 2013.
